ARCHIVES

Auditor Raymond Weiss Finds “Incredible” Protocol Violations–26% Of Patients Were Ineligible For C225 Study

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

September 30, 2005

Duke Retraction May Alter IOM Investigation; Review Panel Membership Announced

November 5, 2010

In Surprising Result, Survey Of Centers Finds Little “Crisis” In Clinical Research

September 29, 1995

ARRA Funding Announcements Listed

April 10, 2009

Funding opportunities listed.

November 12, 2004

HHS, NIH Prepare for Government Shutdown

September 20, 2013